Lorenza Pratali1, Stefano F Rimoldi2, Emrush Rexhaj3, Damian Hutter4, Francesco Faita1, Carlos Salinas Salmòn5, Mercedes Villena5, Rosa Sicari1, Eugenio Picano1, Yves Allemann4, Urs Scherrer6, Claudio Sartori7. 1. Institute of Clinical Physiology, Pisa, Italy. 2. Department of Cardiology, University Hospital of Bern, Bern, Switzerland; Department of Internal Medicine and Botnar Center for Clinical Research, Lausanne, Switzerland. 3. Department of Internal Medicine and Botnar Center for Clinical Research, Lausanne, Switzerland. 4. Department of Cardiology, University Hospital of Bern, Bern, Switzerland. 5. Instituto Boliviano de Biologia de Altura, La Paz, Bolivia. 6. Department of Cardiology, University Hospital of Bern, Bern, Switzerland; Facultad de Ciencias, Departamento de Biología, Universidad de Tarapacá, Arica, Chile. 7. Department of Internal Medicine and Botnar Center for Clinical Research, Lausanne, Switzerland. Electronic address: claudio.sartori@chuv.ch.
Abstract
BACKGROUND: Chronic mountain sickness (CMS) is a major public health problem in mountainous regions of the world. In its more advanced stages, exercise intolerance is often found, but the underlying mechanism is not known. Recent evidence indicates that exercise-induced pulmonary hypertension is markedly exaggerated in CMS. We speculated that this problem may cause pulmonary fluid accumulation and aggravate hypoxemia during exercise. METHODS: We assessed extravascular lung water (chest ultrasonography), pulmonary artery pressure, and left ventricular function in 15 patients with CMS and 20 control subjects at rest and during exercise at 3,600 m. RESULTS: Exercise at high altitude rapidly induced pulmonary interstitial fluid accumulation in all patients but one (14 of 15) with CMS and further aggravated the preexisting hypoxemia. In contrast, in healthy high-altitude dwellers exercise did not induce fluid accumulation in the majority of subjects (16 of 20) (P = .002 vs CMS) and did not alter arterial oxygenation. Exercise-induced pulmonary interstitial fluid accumulation and hypoxemia in patients with CMS was accompanied by a more than two times larger increase of pulmonary artery pressure than in control subjects (P < .001), but no evidence of left ventricular dysfunction. Oxygen inhalation markedly attenuated the exercise-induced pulmonary hypertension (P < .01) and interstitial fluid accumulation (P < .05) in patients with CMS but had no detectable effects in control subjects. CONCLUSIONS: To our knowledge, these findings provide the first direct evidence that exercise induces rapid interstitial lung fluid accumulation and hypoxemia in patients with CMS that appear to be related to exaggerated pulmonary hypertension. We suggest that this problem contributes to exercise intolerance in patients with CMS. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01182792; URL: www.clinicaltrials.gov.
BACKGROUND: Chronic mountain sickness (CMS) is a major public health problem in mountainous regions of the world. In its more advanced stages, exercise intolerance is often found, but the underlying mechanism is not known. Recent evidence indicates that exercise-induced pulmonary hypertension is markedly exaggerated in CMS. We speculated that this problem may cause pulmonary fluid accumulation and aggravate hypoxemia during exercise. METHODS: We assessed extravascular lung water (chest ultrasonography), pulmonary artery pressure, and left ventricular function in 15 patients with CMS and 20 control subjects at rest and during exercise at 3,600 m. RESULTS: Exercise at high altitude rapidly induced pulmonary interstitial fluid accumulation in all patients but one (14 of 15) with CMS and further aggravated the preexisting hypoxemia. In contrast, in healthy high-altitude dwellers exercise did not induce fluid accumulation in the majority of subjects (16 of 20) (P = .002 vs CMS) and did not alter arterial oxygenation. Exercise-induced pulmonary interstitial fluid accumulation and hypoxemia in patients with CMS was accompanied by a more than two times larger increase of pulmonary artery pressure than in control subjects (P < .001), but no evidence of left ventricular dysfunction. Oxygen inhalation markedly attenuated the exercise-induced pulmonary hypertension (P < .01) and interstitial fluid accumulation (P < .05) in patients with CMS but had no detectable effects in control subjects. CONCLUSIONS: To our knowledge, these findings provide the first direct evidence that exercise induces rapid interstitial lung fluid accumulation and hypoxemia in patients with CMS that appear to be related to exaggerated pulmonary hypertension. We suggest that this problem contributes to exercise intolerance in patients with CMS. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01182792; URL: www.clinicaltrials.gov.
Authors: José Luis Macarlupú; Gustavo Vizcardo-Galindo; Rómulo Figueroa-Mujíca; Nicolas Voituron; Jean-Paul Richalet; Francisco C Villafuerte Journal: Exp Physiol Date: 2021-09-30 Impact factor: 2.858
Authors: Alexander B Hansen; Sachin B Amin; Florian Hofstätter; Hendrik Mugele; Lydia L Simpson; Christopher Gasho; Tony G Dawkins; Michael M Tymko; Philip N Ainslie; Francisco C Villafuerte; Christopher M Hearon; Justin S Lawley; Gilbert Moralez Journal: Am J Physiol Heart Circ Physiol Date: 2022-03-25 Impact factor: 5.125
Authors: Samuel J E Lucas; William L Malein; Owen D Thomas; Kimberly M Ashdown; Carla A Rue; Kelsey E Joyce; Charles Newman; Patrick Cadigan; Brian Johnson; Stephen D Myers; Fiona A Myers; Alexander D Wright; John Delamere; Chris H E Imray; Arthur R Bradwell; Mark Edsell Journal: BMJ Open Sport Exerc Med Date: 2021-01-07